Resources
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: SISPCT
Study: SISPCT
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: MAXSEP
Study: MAXSEP
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. We compared intensive insulin therapy with conventional insulin therapy and HES with Ringer’s lactate.
Submitter: René Hänsel
Resource type: Experimental Assay Type
Technology type: Technology Type
Investigation: Efficacy of Volume Substitution and Insulin The...
Study: VISEP
Adjunctive hydrocortisone (HC) therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The case for septic patients without shock remains controversial. We investigated the efficacy of HC in patients with severe sepsis without shock
Restricted Trial Data
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: HYPRESS
Study: HYPRESS
Submitter: Christoph Beger
Resource type: Result Dataset of Clinical Study
Technology type: Technology Type
Investigation: HYPRESS
Study: HYPRESS